论文部分内容阅读
目的：探讨输血后检查丙型肝炎发病率的措施。方法：采用丙型肝炎病毒抗体（抗ＨＣＶ）酶联免疫吸附（ＥＬＩＳＡ）法，对１５９９例献血员作血清抗ＨＣＶ检测。结果：阳性率１０．９４％（１７５／１５９９）。抗ＨＣＶ阳性率２０～３０岁组明显低于３１～４５岁组（Ｐ＜０．００５）；肝功能正常组显著低于肝功能异常组（Ｐ＜０．００５）；献血＜５次组也显著低于献血≥５次组（Ｐ＜０．００５）。结论：选择年轻、肝功能正常的献血员以及控制献血次数是控制输血后丙型肝炎发病率的重要措施。
Objective: To investigate the incidence of hepatitis C after transfusion. Methods: 1599 blood donors were tested for serum anti-HCV using hepatitis C virus antibody (anti-HCV) enzyme-linked immunosorbent assay (ELISA). Results: The positive rate was 10.94% (175/1599). The positive rate of anti-HCV in 20-30 years old group was significantly lower than that in 31-45 years old group (P <0.005), normal liver function group was significantly lower than that in abnormal liver function group (P <0.005) Significantly lower than blood donation ≥ 5 times (P <0.005). CONCLUSIONS: Choosing a young, normal liver function donor and controlling the number of blood donations is an important measure to control the incidence of hepatitis C after blood transfusion.